Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05320211
Other study ID # 10310012110002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 12, 2022
Est. completion date February 28, 2023

Study information

Verified date March 2023
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In persons with chronic hand conditions, orthoses are often prescribed to improve daily-life functioning. In most cases, orthoses are custom manufactured based on a plaster hand model, which is a time-consuming and labor-intensive process. It has been demonstrated that the production time to custom manufacture hand orthoses can be greatly reduced by using three-dimensional (3D) scanning and printing, offering a promising cost-effective alternative to conventional costum manufactured hand orthoses. However, before setting up a cost-effectiveness study in persons with chronic hand conditions, insight into the effectiveness of 3D-printed orthoses on performance of activities of daily living (ADL) is needed, as well as insight into potential cost reductions. To date, this information is largely unknown. The aims of this feasibility study are 1) to collect data on the preliminary effectiveness of 3D-printed orthoses on performance of ADL, satisfaction with the orthosis and quality of life compared to conventional orthoses in persons with chronic hand conditions, and 2) to compare the production time and costs of 3D-printed orthoses with conventional orthoses.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date February 28, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Having a chronic hand-wrist condition due to an injury, or a musculoskeletal disorder, neuromuscular disorder, or neurological disorder; 2. Minimum age of 18 years; 3. Currently wearing a conventional custom manufactured hand orthosis (including a wrist-orthosis, wrist/thumb orthosis or thumb orthosis) for permanent use; 4. Indicated for a new hand orthosis. Exclusion Criteria: 1. Already wearing a 3D-printed orthosis 2. Wearing a silver wrist-orthosis, wrist/thumb orthosis or thumb orthosis 3. Wearing an orthosis prescribed for a dysfunctional hand; 4. Wearing a broken orthosis; 5. Wearing the orthosis only at night; 6. Worsening of disease; 7. Insufficient mastery of the Dutch language.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
3D-printed hand orthosis
3D-printed hand orthoses (intervention) will be compared with custom-fabricated conventional orthoses (control condition at baseline)

Locations

Country Name City State
Netherlands Department of rehabilitation medicine Amsterdam UMC, location AMC Amsterdam

Sponsors (2)

Lead Sponsor Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) ZonMw: The Netherlands Organisation for Health Research and Development

Country where clinical trial is conducted

Netherlands, 

References & Publications (2)

Oud T, Kerkum Y, de Groot P, Gijsbers H, Nollet F, Brehm MA. Production Time and User Satisfaction of 3-Dimensional Printed Orthoses For Chronic Hand Conditions Compared With Conventional Orthoses: A Prospective Case Series. J Rehabil Med Clin Commun. 2021 Feb 12;4:1000048. doi: 10.2340/20030711-1000048. eCollection 2021. — View Citation

Oud TAM, Lazzari E, Gijsbers HJH, Gobbo M, Nollet F, Brehm MA. Effectiveness of 3D-printed orthoses for traumatic and chronic hand conditions: A scoping review. PLoS One. 2021 Nov 18;16(11):e0260271. doi: 10.1371/journal.pone.0260271. eCollection 2021. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Adverse events The following adverse events reported by the participant or observed by the investigator or orthotist will be recorded; pressure sores, abrasions, pain due to the orthosis, and material damage of the orthosis. up to 4 months post intervention
Primary Change from baseline in performance of ADL on the custom short form of the Dutch-Flemish Patient-Reported Outcomes Measurement Information System - Upper extremity (DF-PROMIS-UE) at 4 months post-intervention. The short form DF-PROMIS-UE contains 25 items from the DF-PROMIS-UE 46-item bank. Patients will rate how easily they can perform each activity on a 5-point scale, ranging from "without any difficulty" (score 4 or 5) to "unable to do" (score 1). For each activity, the question was added whether participants use their orthosis for that specific activity. The total score will be expressed as a T-score, which is a standardized score, with 50 representing the average score of the US general population and 10 being its standard deviation (SD). Note. For this study, the reliability of the DF-PROMIS-UE in persons with chronic hand conditions will be determined. 2 weeks pre-intervention; baseline; 1 month post-intervention; 4 months post-intervention
Secondary Change from baseline in performance of ADL, overall hand function, pain, work, performance, aesthetics, and satisfaction on the Michigan Hand Questionnaire-Dutch Language version (MHQ-DLV) at 4 months post-intervention. MHQ-DVL domain items are scored from 0 - 100, in which 100 is the best possible ability, while for pain a score of 0 indicates no pain. The total MHQ-DLV score is calculated as the mean of all 6 domains (after converting pain from a "best score of 0" scale to a "best score of 100" scale). Note. For this study, the reliability of the MHQ-DLV in persons with chronic hand conditions will be determined. 2 weeks pre-intervention; baseline; 1 month post-intervention; 4 months post-intervention
Secondary Change from baseline in satisfaction assessed with the Dutch version of the Client Satisfaction with Device (CSD) module of the Orthotics and Prosthetics User's Survey (OPUS) at 4 months post-intervention. The CSD contains 9 items rated on a 5-point Likert scale ranging from 0 ('strongly disagree') to 4 ('strongly agree), with a total score ranging from 0-36. Since the CSD is not yet available in Dutch, the investigators will translate it into the Dutch language and assess its content validity, structural validity, and reliability in Dutch orthotic users. 2 weeks pre-intervention; baseline; 1 month post-intervention; 4 months post-intervention
Secondary Change from baseline in satisfaction assessed with the Dutch version of the Quebec User Evaluation of Satisfaction with Assistive Technology (D-QUEST) at 4 months post-intervention The D-QUEST assesses satisfaction with aspects related to the device and provided services. For this study, only the device-part of the D-QUEST will be used, which comprises 8 questions about certain characteristics of the orthotic device, all scored on a 5-point scale (from 'not satisfied at all' to 'very satisfied'), with a total score ranging from 8-40 (with 40 being the best possible satisfaction score). Baseline; 1 month post-intervention; 4 months post-intervention
Secondary Change in quality of life on the 5-dimension 5-level EuroQol (EQ-5D-5L) at 4 months post-intervention. The EQ-5D-5L contains five questions about mobility, self-care, usual activities, pain/discomfort, and anxiety and depression scored on a 5-point scale indicating the degree of problems with each dimension and one question about experienced health scored on a 0-100 visual analogue scale. Baseline; 1 month post-intervention, 4 months post-intervention
Secondary Production time of the orthosis (in minutes). For each step in manufacturing the orthosis until final delivery, time will be recorded (with a stopwatch). From start of the intervention up to delivery of the orthosis
Secondary Production costs of the orthosis (in euro). Costs of the conventional orthoses will be retrospectively inventoried from the administration records of OIM. Costs related to the manufacturing of the 3D-printed orthoses will be prospectively assessed. From start of the intervention up to delivery of the orthosis
Secondary Change from baseline in personal goals at 4 month post-intervention. An in-house usability questionnaire will be used to inventory information on personal goals of the orthosis, and whether this goal has been achieved (scored on a 10-point-scale, ranging from 1: not achieved at all to 10: very well achieved). Baseline; 1 month post-intervention, 4 months post-intervention
Secondary Change from baseline in orthosis use at 4 month post-intervention. An in-house usability questionnaire will be used to inventory how often the orthosis is used, classified in 5 categories; ranging from never until 6-7 days a week. Baseline; 1 month post-intervention, 4 months post-intervention
Secondary Patient and therapist experiences with the 3D orthosis Experiences of patients and health care providers with respect to the time window of the 3D intervention and satisfaction with the treatment process will be assessed with an in-house questionnaire, with items scored on a 5-point Likert scale. 1 month post-treatment
Secondary Number of visits for fabrication of the 3D orthosis The total number of visits for fabricating the 3D orthosis will be obtained from the administration records of OIM From start of the intervention up to delivery of the orthosis
See also
  Status Clinical Trial Phase
Recruiting NCT05887778 - Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery Phase 4
Recruiting NCT06086392 - Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery Phase 4
Completed NCT06155617 - Pain, Range of Motion, Edema, Sensibility, Strength (PRESS) & Self-reported Function Create a Comprehensive Score N/A
Completed NCT04625868 - Effectiveness of a Preoperative Educational Video for Reducing Opioid Consumption After Hand Surgery N/A
Not yet recruiting NCT04907812 - The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery Phase 4
Recruiting NCT03702387 - Evaluation of Second Esmarch Application on Intravenous Regional Anesthesia Effectiveness N/A
Completed NCT03195413 - Early Ultrasound-guided Nerve Block for Painful Hand Injuries in the Emergency Department N/A
Completed NCT04215614 - Lateral Sagittal vs Costoclavicular Brachial Plexus Block in Children N/A
Completed NCT03557073 - The Effects of Postoperative Physician Phone Calls for Hand and Wrist Fractures N/A
Recruiting NCT04646343 - Cross-cultural Adaptation and Validation of the CISS and the PWES Questionnaire in Patients With Hand Pathologies.
Completed NCT04174729 - System for Quantifying the Functional Strength of the Grip and Pinch Movements N/A
Completed NCT04673877 - Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration Phase 1
Recruiting NCT04460521 - The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome Phase 4
Completed NCT03750045 - Grip Movement Training for Adults With Fine Motor Limitation N/A